CHICAGO, Nov. 12, 2020 /PRNewswire/ -- The Chartis Group, a leading healthcare advisory and analytics firm, announced today its acquisition of Jarrard Phillips Cate & Hancock, Inc., a Nashville-based strategic communications and change management firm serving the healthcare industry.
Founded in 2006, award-winning Jarrard Inc. ranks among the top 10 healthcare communications firms in the nation. Specializing in areas such as issue navigation, transformation adoption, change management, strategic positioning and M&A, Jarrard has served more than 500 healthcare provider clients.
Jarrard joins Chartis at a time of great promise and challenge in the nation's healthcare delivery landscape. US hospitals, health systems and other providers are confronted with dynamic operational, clinical and financial challenges while simultaneously being presented with unlimited opportunities for disruption and innovation. In both cases, organizations are facing the need to evolve and continue to grow and transform – which requires not only new strategic, clinical, digital and operating models – but also the ability to ensure their effective implementation and adoption. To that end, Jarrard brings great complementary strengths to Chartis.
"The power of what our two organizations can do together to help clients fully achieve their strategic and operational objectives could not be greater," said Ken Graboys, CEO of The Chartis Group. "We believe successful, sustainable transformation requires effective change management and communications. By partnering with Jarrard, we can more effectively deliver results for our clients and the healthcare industry at large."
"We are combining the power of effective communications with the exceptional strategic, financial, technological and operational expertise of Chartis," said David Jarrard, CEO of Jarrard Inc. "We are bringing together the art and the science of change to a rapidly-evolving industry and in service to a mission – shared by both organizations – to make healthcare better."
The acquisition of Jarrard furthers Chartis' commitment to providing US healthcare providers best-in-class advisory capabilities. Under the partnership, like other sister companies, Jarrard retains its brand, culture, leadership and approach to client service, while being augmented by the expertise and resources of Chartis. The acquisition of Jarrard follows Chartis' acquisition of The Greeley Company in 2019 and Oncology Solutions in 2018.
PALAZZO served as exclusive financial advisor to Jarrard Phillips Cate & Hancock Inc. in this transaction.
About Jarrard Inc.
With offices in Nashville, Tenn. and Chicago, Jarrard Phillips Cate & Hancock, Inc. is a U.S. top 10 strategic communications consulting firm for the nation's leading healthcare providers experiencing significant change, challenge or opportunity. Founded in 2006, the firm has worked with more than 500 clients in 45 states and has led communications and political strategy for $60 billion in announced M&A and partnership transactions. The firm specializes in M&A, change management, issue navigation and strategic positioning, and has recently worked alongside 75-plus healthcare organizations navigating the impact of COVID-19. For more information, visit jarrardinc.com.
About The Chartis Group
The Chartis Group® (Chartis) provides comprehensive advisory services and analytics to the healthcare industry. With an unparalleled depth of expertise in strategic planning, performance excellence, informatics and technology, digital and emerging technologies, and health analytics, Chartis helps leading academic medical centers, integrated delivery networks, children's hospitals and healthcare service organizations achieve transformative results. Chartis has offices in Atlanta, Boston, Chicago, New York, Minneapolis and San Francisco. For more information, visit www.chartis.com.
SOURCE The Chartis Group